Home › Calculator › EKDHF Dividend Calculator 2026
EKDHF Dividend DRIP Calculator 2026
588.24% YieldHealthcareEKF Diagnostics Holdings plc · OTC
Price: $0.34 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When EKDHF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your EKDHF snowball 📈
$10,000 in EKDHF → $255.0K in 10 years · $1,066.45/month
About EKF Diagnostics Holdings plc (EKDHF) — Dividend Analysis 2026
EKF Diagnostics Holdings plc, a company founded in Cardiff, United Kingdom in 1990, specializes in the global design, development, manufacture, and sale of diagnostic instruments, reagents, and supporting products. Operating across Europe, the Middle East, the Americas, Asia, and Africa, the company offers a comprehensive range of solutions for clinical diagnostics. Their product line encompasses various diagnostic tools, including hemoglobin analyzers such as the hand-held DiaSpect Tm, DiaSpect Hemoglobin T, and the lab-quality Hemo Control, alongside the HemataStat II microhematocrit centrifuge. For diabetes management and monitoring, EKF provides glycated hemoglobin analyzers like Quo-Lab A1c and Quo-Test A1c, in addition to glucose and lactate analyzers such as the Biosen C-Line GP+, C-Line Clinic, and Lactate Scout 4. The company also manufactures specialized analyzers, including the STAT-Site M Beta-hydroxybutyrate analyzer, Creamatocrit Plus for assessing lipid concentration and calorific density in mothers' milk, and pregnancy tests like QuPID and True20. EKF's portfolio extends to clinical chemical analyzers and reagents covering ketosis monitoring (Beta-hydroxybutyrate, Nitro-tab Ketone tablets), Glycated Albumin, Glycated Serum Protein, and Procalcitonin, a marker for bacterial infection and sepsis. Additional offerings include RaPET Serology immunoassay kits, rapid tests like QuStick Strep A for Strep A infections, and various laboratory instruments such as the Altair 240 chemistry analyzer, Excel semi-automated chemistry analyzer, and Micro 12 centrifuge. EKF also supplies Hema-Screen Serology for early colorectal cancer detection, the Uri-Trak 120 urine analyzer, and provides kits and services related to COVID-19. Beyond product sales, the company offers contract manufacturing solutions to third-party businesses and provides laboratory services.
Compare EKDHF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full EKDHF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open EKDHF position with:
🌍 EKDHF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold EKDHF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 588.24% | 585.44% | $58,824 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 500.00% | 497.20% | $50,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 470.59% | 467.79% | $47,059 / yr |
| 🇬🇧 UK ISA | 0% | 588.24% | 585.44% | $58,824 / yr |
| 🇬🇧 UK Taxable | 8.75% | 536.77% | 533.97% | $53,677 / yr |
| 🇨🇦 TFSA | 0% | 588.24% | 585.44% | $58,824 / yr |
| 🇨🇦 CA Taxable | 25% | 441.18% | 438.38% | $44,118 / yr |
| 🇦🇺 Super (pension) | 15% | 500.00% | 497.20% | $50,000 / yr |
| 🇦🇺 AU Taxable | 30% | 411.77% | 408.97% | $41,177 / yr |
| 🇩🇪 DE Taxable | 26.375% | 433.09% | 430.29% | $43,309 / yr |
| 🇫🇷 FR Taxable | 30% | 411.77% | 408.97% | $41,177 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 EKDHF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 EKDHF Dividend Payment Schedule
EKDHF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 EKDHF vs Healthcare Benchmarks
How EKDHF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for EKDHF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ EKDHF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the EKDHF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
EKF Diagnostics Holdings plc (EKDHF) is currently trading at $0.34, 69% below its 52-week high. The current dividend yield is 588.24% based on an annual payout of $2.00 per share.
EKDHF (EKF Diagnostics Holdings plc) — 588.24% Dividend Yield Analysis
EKF Diagnostics Holdings plc (EKDHF) is a healthcare stock currently trading at $0.34 with a dividend yield of 588.24%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, EKDHF has grown its dividend at a compound annual rate of 50.0%.
- Above-average yield (588.24%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.